跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 332 条关于
“Apremilast Viatris”
全部
332
临床试验
171
药物
37
机构
17
资讯
107
去年
EMA's CHMP Recommends 10 New Medicines, Including Novel Therapies and Biosimilars
去年
Apremilast Shows Promise in Early Oligoarticular Psoriatic Arthritis
9个月前
Zasocitinib Shows Phase 3 Superiority Over Apremilast in Dermatology Trials
9个月前
Deucravacitinib Shows Efficacy in Psoriasis Patients Who Failed Apremilast Treatment
9个月前
Apremilast Demonstrates Sustained Efficacy in Moderate to Severe Genital Psoriasis Through 32 Weeks
去年
FDA-Approved Apremilast Shows Dual Potential for Alcohol Use Disorder and Pain Management
去年
Apremilast Shows Promise in Reducing Alcohol Consumption in Clinical Study
去年
Viatris Wins Patent Battle Against Novo Nordisk Over Generic Wegovy
2年前
Viatris Expands Pipeline with Idorsia Collaboration, Focuses on Cardiovascular and Autoimmune Therapies
去年
Viatris Reports Q1 2025 Results: Pipeline Progress Despite Financial Challenges
第 1 页,共 11 页
上一页
下一页